A recent report published by Infinium Global Research on brain tumor diagnosis and treatment market provides an in-depth analysis of segments and sub-segments in the global as well as regional brain tumor diagnosis and treatment market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional brain tumor diagnosis and treatment market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global brain tumor diagnosis and treatment market. According to the report, the global brain tumor diagnosis and treatment market are projected to grow at a CAGR of 8.7% over the forecast period of 2018-2024.
Brain tumor is an abnormal growth of cells inside the brain. Brain tumors are classified into two types such as primary and secondary. Primary tumor starts within the brain and secondary tumor develops in the lung, skin, kidney or other parts and spread to the brain. Several method are used for brain tumor diagnosis such as MRI, CT scan, PET-CT scan, EEG, molecular testing. Additionally, surgery, radiation therapy, radiosurgery, chemotherapy, targeted drug therapy, immunotherapy are used for its treatment.
The increasing occurrence of brain tumors (Glioblastoma) across the globe coupled with growing geriatric population are fuelling the demand of brain tumor diagnosis and treatment market. According to National Brain Tumors Society, nearly 700,000 people in the United States are living with a primary brain tumor, and approximately 78,000 cases were diagnosed in 2016. Additionally, growing public private partnership in healthcare sector creates a positive impact on the diagnostic imaging technique that in turn promotes the growth of brain tumor diagnosis and treatment market. In addition, increased focus on precision medicine and growing awareness regarding the latest technological advancement in therapies and treatment are primary factors responsible for the growth of market. However, high cost of diagnostic and treatment and less availability of tumor specific drugs are hampering the growth of brain tumor diagnosis and treatment market. Ongoing development in molecular diagnostics to understand cell biology at cellular level of malignancy. In addition, development in technologically advanced product and therapies creates growth opportunities for brain tumor diagnosis and treatment market during forecast period.
Among the geographies, North America is the dominant region in brain tumor diagnosis and treatment market. The U.S. accounted for the largest revenue share in this market. The growing inclination towards advanced technologies amongst the population and highly developed infrastructure promotes the growth of market. Furthermore, the rapid rise in the number of people diagnosed with brain tumors and extensive research and development activities fuels the demand of brain tumor diagnosis and treatment market in the North America region. On the other hand, Europe is expected to be the fastest growing region during the forecast period due to high demand from the countries such as Germany and U.K. The factors such as growing awareness related to advanced technology, high prevalence of brain tumors and rise in geriatric population promotes the growth of brain tumor diagnosis and treatment market.
The report on global brain tumor diagnosis and treatment market covers segments such as diagnosis type, treatment type, and product type. On the basis of diagnosis type, the sub-markets include MRI, CT scan, PET-CT scan, EEG, molecular testing, and others. On the basis of treatment type, the sub-markets include surgery, radiation therapy, radiosurgery, chemotherapy, targeted drug therapy, and immunotherapy. On the basis of product type, the sub-markets include primary brain tumor and secondary brain tumor.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016-2024. The countries covered in the North America region include the U.S., Canada, and Mexico while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in this region. The Asia-pacific region offers substantial potential for the market growth owing to rapid growth in markets such as India and China.
The report provides profiles of the companies in the market such as GE Healthcare, Merck & Co., Inc, AstraZeneca, Carestream Health, Philips Healthcare, Siemens Healthcare Private Limited, Shimadzu Corporation, Hitachi Medical Systems, Pfizer, Inc, and Toshiba Medical Systems.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of brain tumor diagnosis and treatment market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter